Press Releases | Page 3 of 43

Researchers Question Editorial Bias in COVID-19 Vaccine Debate

February 16, 2026

“By the end of this commentary, it will be evident how a purported 'general scientific consensus' may have been artificially engineered by selectively prioritizing studies aligned with the established narrative.”… read more

Oncotarget

Case Report Explores Potential Link Between mRNA COVID-19 Vaccines and Cancer

February 11, 2026

“In this article, we assess the risk of developing haematopoietic cancers post-modRNA vaccination based on current scientific literature and explore the reported potential genetic and molecular mechanisms involved in disease… read more

Oncotarget

New Hypothesis Links HPV E6 and SARS‑CoV‑2 Spike Proteins to Reduced p53 Activity

January 13, 2026

“Thus, the present hypothesis is that virally encoded proteins such as HPV-E6 or SARS-COV-2 Spike may cooperate in suppressing host defenses including tumor suppressor mechanisms involving p53.” BUFFALO, NY -… read more

Oncotarget

Evaluation of Cancer Reports Following COVID-19 Vaccination and Infection

January 8, 2026

“The collective world-wide evidence from 2020–2025 underscores a biologically plausible connection between COVID-19 vaccination and cancer.” BUFFALO, NY - January 8, 2026 – A new review was published in Oncotarget… read more

Oncotarget

Colorectal Cancer Survival Predicted by AI Using Clinical and Molecular Features

December 17, 2025

“The clinical and biological features proposed here in conjunction with ML can improve the interpretation of CRC mechanisms and predict patient survival.” BUFFALO, NY - December 17, 2025 – A… read more

Oncotarget

Probiotic Bifidobacterium May Boost Cancer Treatment and Suppress Tumors

November 18, 2025

“The anticancer properties of bifidobacterium may also stem from its ability to detoxify carcinogens and transform dietary elements.” BUFFALO, NY - November 18, 2025 – A new review was published… read more